NO20006383D0 - Fremgangsmåte for behandling - Google Patents

Fremgangsmåte for behandling

Info

Publication number
NO20006383D0
NO20006383D0 NO20006383A NO20006383A NO20006383D0 NO 20006383 D0 NO20006383 D0 NO 20006383D0 NO 20006383 A NO20006383 A NO 20006383A NO 20006383 A NO20006383 A NO 20006383A NO 20006383 D0 NO20006383 D0 NO 20006383D0
Authority
NO
Norway
Prior art keywords
treatment
Prior art date
Application number
NO20006383A
Other languages
English (en)
Other versions
NO20006383L (no
Inventor
Martin X Steiner
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20006383D0 publication Critical patent/NO20006383D0/no
Publication of NO20006383L publication Critical patent/NO20006383L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20006383A 1998-06-16 2000-12-14 Fremgangsmåte for behandling NO20006383L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812941.4A GB9812941D0 (en) 1998-06-16 1998-06-16 Method of treatment
PCT/US1999/013623 WO1999065491A1 (en) 1998-06-16 1999-06-16 Method of treatment

Publications (2)

Publication Number Publication Date
NO20006383D0 true NO20006383D0 (no) 2000-12-14
NO20006383L NO20006383L (no) 2000-12-14

Family

ID=10833832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006383A NO20006383L (no) 1998-06-16 2000-12-14 Fremgangsmåte for behandling

Country Status (20)

Country Link
EP (1) EP1087766A4 (no)
JP (1) JP2002518330A (no)
KR (1) KR20010052895A (no)
CN (1) CN1305379A (no)
AP (1) AP2000002002A0 (no)
AU (1) AU740749B2 (no)
BG (1) BG105127A (no)
BR (1) BR9911150A (no)
CA (1) CA2335236A1 (no)
CZ (1) CZ20004698A3 (no)
EA (1) EA003584B1 (no)
GB (1) GB9812941D0 (no)
HU (1) HUP0102507A3 (no)
IL (1) IL139943A0 (no)
NO (1) NO20006383L (no)
NZ (1) NZ508532A (no)
PL (1) PL345261A1 (no)
SK (1) SK19192000A3 (no)
WO (1) WO1999065491A1 (no)
ZA (1) ZA200007396B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507504A (ja) * 2000-08-28 2004-03-11 シントン・ベスローテン・フェンノートシャップ パロキセチン組成物およびその製造方法
AU2002360775B9 (en) * 2001-12-28 2008-07-24 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
EP1791531A1 (en) * 2004-08-20 2007-06-06 Alpharma, Inc. Paroxetine formulations
FR2926221A1 (fr) * 2008-01-14 2009-07-17 Tassin Thomas Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
CA2096853A1 (en) * 1990-11-24 1992-05-25 Anthony Michael Johnson Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method

Also Published As

Publication number Publication date
WO1999065491A1 (en) 1999-12-23
SK19192000A3 (sk) 2001-05-10
IL139943A0 (en) 2002-02-10
EP1087766A4 (en) 2001-11-21
BG105127A (en) 2001-11-30
AU740749B2 (en) 2001-11-15
CN1305379A (zh) 2001-07-25
CA2335236A1 (en) 1999-12-23
AU4688599A (en) 2000-01-05
JP2002518330A (ja) 2002-06-25
CZ20004698A3 (cs) 2002-02-13
EP1087766A1 (en) 2001-04-04
GB9812941D0 (en) 1998-08-12
NZ508532A (en) 2003-08-29
HUP0102507A3 (en) 2003-12-29
NO20006383L (no) 2000-12-14
EA003584B1 (ru) 2003-06-26
PL345261A1 (en) 2001-12-03
HUP0102507A2 (hu) 2002-05-29
EA200100041A1 (ru) 2001-06-25
ZA200007396B (en) 2002-02-27
KR20010052895A (ko) 2001-06-25
BR9911150A (pt) 2001-03-06
AP2000002002A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
DE69828821D1 (de) Wasserbehandlungsverfahren
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ID27191A (id) Metode untuk pengobatan insomnia
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20006383D0 (no) Fremgangsmåte for behandling
ID22607A (id) Proses perlakuan bahan-bahan tekstil
ID26083A (id) Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns
NO20012301D0 (no) Ny fremgangsmåte for behandling
NO996166D0 (no) Fremgangsmåte for behandling av avluter
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
EE9800006A (et) Jäätmete töötlemise meetod
ID29414A (id) Pengobatan depresi
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки
MD676F1 (ro) Metoda de tratament al rinosinuzitelor Method for treatment of the rhinosinusitis
UA33970A (uk) Спосіб лікування періодонтиту
ID26641A (id) Metoda pengobatan
SE9802791D0 (sv) Behandlingsmetod
EG24158A (en) Novel method of treatment
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
TH34294B (th) กระบวนการสำหรับการเตรียมคลอโรเบบโซซาโซล
UA33595A (uk) Спосіб лікування простої шизофренії
GB9824790D0 (en) Novel method of treatment